ATLANTA, May 7, 2019 /PRNewswire/ — DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of innovative healthcare services and solutions to federal agencies, today announced financial results for its fiscal second quarter ended March 31, 2019.
Highlights
Management Discussion
“Second quarter results once again illustrated the strong cash flow potential of our operations,” stated DLH President and Chief Executive Officer Zach Parker. “While sales were down slightly from 2018, gross margins rose to 23.9% and we generated $8.5 million of cash – which we used to completely pay off the remaining $7.4 million of senior debt during the period. Our balance sheet is in excellent condition such that, while we continue to bid on larger, more complex opportunities within our core markets, we’re in a strong position to look at attractive acquisitions that can bolster our capabilities and growth profile. We remain on track to post a solid year of financial performance and are optimistic about the market outlook for fiscal 2019 and beyond.”
Results for the Three Months Ended March 31, 2019
Revenue for the second quarter of fiscal 2019 was $33.8 million versus $34.4 million in the prior-year period, with the slight decrease reflecting normal variation in service delivery.
Gross profit was $8.1 million for the quarter, an increase of approximately $0.6 million, or 8.4%, over the second quarter of fiscal 2018. As a percent of revenue, the Company’s gross margin was 23.9% in 2019 versus 21.7% in the prior-year period. General and Administrative (“G&A”) expenses were $5.2 million for the quarter compared to $4.7 million in fiscal 2018, with the increase principally due to higher corporate development costs. Depreciation and amortization was $0.6 million in both fiscal year second quarters.
Income from operations was $2.3 million for the quarter versus $2.2 million in the prior-year period, and income before taxes was $1.8 million for the quarter versus $1.9 million in fiscal 2018, reflecting higher interest expense in 2019. The increase in interest expense was due to the write-off of $0.4 million of unamortized deferred financing costs from early pay-off of the term loan.
For the three months ended March 31, 2019 DLH recorded a $0.5 million provision for tax expense versus $0.6 million for the second quarter of 2018. The Company reported net income of approximately $1.3 million, or $0.10 per diluted share, for the second quarters of both fiscal 2019 and fiscal 2018.
On a non-GAAP basis, Earnings Before Interest Tax Depreciation and Amortization (“EBITDA”) for the three months ended March 31, 2019 was approximately $2.9 million versus $2.8 million in the prior-year period. Growth was attributable to the higher gross profit, as described above.
Balance Sheet and Cash Flow
Cash as of March 31, 2019 was $5.5 million, and the Company’s senior debt was $0.0 million, versus cash of $6.4 million and senior debt of $7.7 million as of September 30, 2018. Regarding cash flow, for the first six months of fiscal 2019 DLH generated approximately $6.8 million in cash from operations, versus $4.0 million last year, reflecting higher net income and improved working capital.
Conference Call and Webcast Details
DLH management will discuss second quarter results and provide a general business update, including current competitive conditions and strategies, during a conference call beginning at 11:00 AM Eastern Time tomorrow, May 8, 2019. Interested parties may listen to the conference call by dialing 888-347-5290 or 412-317-5256. Presentation materials will also be posted on the Investor Relations section of the DLH website prior to the commencement of the conference call.
A digital recording of the conference call will be available for replay two hours after the completion of the call and can be accessed on the DLH Investor Relations website or by dialing 877-344-7529 and entering the conference ID 100127619.
About DLH
DLH (NASDAQ:DLHC) serves federal government clients throughout the United States and abroad delivering technology enabled solutions in key health and human services programs. The Company’s core competencies and consulting services include assessment and compliance monitoring, program management, health IT systems integration, data analytics, medical logistics, and pharmacy solutions. DLH has over 1,600 employees serving numerous government agencies. For more information, visit the corporate website at www.dlhcorp.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:
This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or DLH`s future financial performance. Any statements that are not statements of historical fact (including without limitation statements to the effect that the Company or its management “believes”, “expects”, “anticipates”, “plans”, “intends” and similar expressions) should be considered forward looking statements that involve risks and uncertainties which could cause actual events or DLH’s actual results to differ materially from those indicated by the forward-looking statements. Those risks and uncertainties include, but are not limited to, the following: failure to achieve contract awards in connection with re-competes for present business and/or competition for new business; the risks and uncertainties associated with client interest in and purchases of new services; changes in client budgetary priorities; government contract procurement (such as bid protest, small business set asides, loss of work due to organizational conflicts of interest, etc.) and termination risks; the ability to successfully integrate the operations of our recent and any future acquisitions; and other risks described in our SEC filings. For a discussion of such risks and uncertainties which could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” in the Company’s periodic reports filed with the SEC, including our Annual Report on Form 10-K for the fiscal year ended September 30, 2018, as well as interim quarterly filings thereafter. The forward-looking statements contained herein are made as of the date hereof and may become outdated over time. The Company does not assume any responsibility for updating forward-looking statements.
CONTACTS:
INVESTOR RELATIONS
Contact: Chris Witty
Phone: 646-438-9385
Email: cwitty@darrowir.com
TABLES TO FOLLOW
|
DLH HOLDINGS CORP. |
||||||||||||
|
(unaudited) |
(unaudited) |
|||||||||||
|
Three Months Ended |
Six Months Ended |
|||||||||||
|
March 31, |
March 31, |
|||||||||||
|
2019 |
2018 |
2019 |
2018 |
|||||||||
|
Revenue |
$ |
33,756 |
$ |
34,401 |
$ |
67,508 |
$ |
64,616 |
||||
|
Direct expenses |
25,682 |
26,953 |
$ |
51,647 |
$ |
50,636 |
||||||
|
Gross margin |
8,074 |
7,448 |
$ |
15,861 |
$ |
13,980 |
||||||
|
General and administrative expenses |
5,188 |
4,684 |
$ |
9,855 |
$ |
9,564 |
||||||
|
Depreciation and amortization |
560 |
560 |
$ |
1,123 |
$ |
1,066 |
||||||
|
Income from operations |
2,326 |
2,204 |
$ |
4,883 |
$ |
3,350 |
||||||
|
Interest expense, net |
544 |
261 |
$ |
721 |
$ |
539 |
||||||
|
Income before income taxes |
1,782 |
1,943 |
$ |
4,162 |
$ |
2,811 |
||||||
|
Income tax expense |
517 |
627 |
$ |
1,207 |
$ |
4,346 |
||||||
|
Net income (loss) |
$ |
1,265 |
$ |
1,316 |
$ |
2,955 |
$ |
(1,535) |
||||
|
Net income (loss) per share – basic |
$ |
0.11 |
$ |
0.11 |
$ |
0.25 |
$ |
(0.13) |
||||
|
Net income (loss) per share – diluted |
$ |
0.10 |
$ |
0.10 |
$ |
0.23 |
$ |
(0.13) |
||||
|
Weighted average common shares outstanding |
||||||||||||
|
Basic |
12,036 |
11,889 |
11,999 |
11,863 |
||||||||
|
Diluted |
13,087 |
12,886 |
13,030 |
11,863 |
||||||||
|
DLH HOLDINGS CORP. |
||||||
|
March 31, |
September 30, |
|||||
|
(unaudited) |
||||||
|
ASSETS |
||||||
|
Current assets: |
||||||
|
Cash and cash equivalents |
$ |
5,461 |
$ |
6,355 |
||
|
Accounts receivable |
9,396 |
10,280 |
||||
|
Other current assets |
1,509 |
760 |
||||
|
Total current assets |
16,366 |
17,395 |
||||
|
Equipment and improvements, net |
1,328 |
1,566 |
||||
|
Deferred taxes, net |
3,160 |
4,137 |
||||
|
Goodwill |
25,989 |
25,989 |
||||
|
Intangible assets, net |
12,483 |
13,365 |
||||
|
Other long-term assets |
201 |
89 |
||||
|
Total assets |
$ |
59,527 |
$ |
62,541 |
||
|
LIABILITIES AND SHAREHOLDERS’ EQUITY |
||||||
|
Current liabilities: |
||||||
|
Accrued payroll |
5,217 |
4,983 |
||||
|
Accounts payable, accrued expenses, and other current liabilities |
11,305 |
10,950 |
||||
|
Total current liabilities |
16,522 |
15,933 |
||||
|
Total long term liabilities |
201 |
7,190 |
||||
|
Total liabilities |
16,723 |
23,123 |
||||
|
Commitments and contingencies |
||||||
|
Shareholders’ equity: |
||||||
|
Common stock, $0.001 par value; authorized 40,000 shares; issued and outstanding |
12 |
12 |
||||
|
Additional paid-in capital |
84,716 |
84,285 |
||||
|
Accumulated deficit |
(41,924) |
(44,879) |
||||
|
Total shareholders’ equity |
42,804 |
39,418 |
||||
|
Total liabilities and shareholders’ equity |
$ |
59,527 |
$ |
62,541 |
||
|
DLH HOLDINGS CORP. |
||||||
|
(unaudited) |
||||||
|
Six Months Ended |
||||||
|
March 31, |
||||||
|
2019 |
2018 |
|||||
|
Operating activities |
||||||
|
Net income (loss) |
$ |
2,955 |
$ |
(1,535) |
||
|
Adjustments to reconcile net income (loss) to net cash provided by operating |
||||||
|
Depreciation and amortization expense |
1,123 |
1,066 |
||||
|
Amortization of deferred financing costs |
534 |
132 |
||||
|
Stock based compensation expense |
392 |
928 |
||||
|
Deferred taxes, net |
978 |
4,166 |
||||
|
Changes in operating assets and liabilities |
||||||
|
Accounts receivable |
884 |
(427) |
||||
|
Other current assets |
(749) |
(347) |
||||
|
Accounts payable, accrued expenses, and other current liabilities |
589 |
(31) |
||||
|
Other long term assets/liabilities |
73 |
44 |
||||
|
Net cash provided by operating activities |
6,779 |
3,996 |
||||
|
Investing activities |
||||||
|
Purchase of equipment and improvements |
(4) |
(588) |
||||
|
Net cash used in investing activities |
(4) |
(588) |
||||
|
Financing activities |
||||||
|
Repayments on senior debt |
(7,708) |
(4,793) |
||||
|
Repayments of capital lease obligations |
— |
(5) |
||||
|
Proceeds from stock option exercise |
39 |
46 |
||||
|
Net cash used in financing activities |
(7,669) |
(4,752) |
||||
|
Net change in cash and cash equivalents |
(894) |
(1,344) |
||||
|
Cash and cash equivalents at beginning of year |
6,355 |
4,930 |
||||
|
Cash and cash equivalents at end of year |
$ |
5,461 |
$ |
3,586 |
||
|
Supplemental disclosures of cash flow information |
||||||
|
Cash paid during the period for interest |
$ |
234 |
$ |
427 |
||
|
Cash paid during the period for income taxes |
$ |
247 |
$ |
578 |
||
|
Supplemental disclosures of non-cash financing activity |
||||||
|
Derivative warrant liability reclassified as equity |
$ |
— |
$ |
(306) |
||
|
Noncash issuance of stock upon exercise of options |
$ |
— |
$ |
25 |
||
|
Revenue Metrics |
||||||
|
Six Months Ended |
||||||
|
March 31, |
March 31, |
|||||
|
2019 |
2018 |
|||||
|
Market Mix: |
||||||
|
Defense/VA |
69 |
% |
62 |
% |
||
|
Human Services and Solutions |
29 |
% |
35 |
% |
||
|
Public Health/Life Sciences |
2 |
% |
3 |
% |
||
|
Contract Mix: |
||||||
|
Time and materials |
97 |
% |
97 |
% |
||
|
Cost plus fixed fee |
2 |
% |
2 |
% |
||
|
Firm fixed price |
1 |
% |
1 |
% |
||
|
Prime vs Sub: |
||||||
|
Prime |
99 |
% |
99 |
% |
||
|
Subcontractor |
1 |
% |
1 |
% |
||
Non-GAAP Financial Measures
The Company uses EBITDA as a supplemental non-GAAP measure of our performance. DLH defines EBITDA as net income excluding (i) interest expense, (ii) provision for or benefit from income taxes and (iii) depreciation and amortization.
In addition, we are also reporting our net income excluding the impact of the Tax Cut and Jobs Act of 2017 to demonstrate the impact of the tax law change. On December 22, 2017, the Tax Cut and Jobs Act was enacted, which, among other things, reduced corporate tax rates and revised rules regarding the usability of net operating losses. These changes have resulted in a tax provision of $3.4 million for the first quarter of fiscal 2018 associated with revaluing the benefit of our net operating losses. For comparability, the tax provision for the prior year period has been restated using the current year rate of 29%.
These non-GAAP measures of performance are used by management to conduct and evaluate its business during its regular review of operating results for the periods presented. Management and the Company’s Board utilize these non-GAAP measures to make decisions about the use of the Company’s resources, analyze performance between periods, develop internal projections and measure management performance. DLH believes that these non-GAAP measures are useful to investors in evaluating the Company’s ongoing operating and financial results and understanding how such results compare with the Company’s historical performance.
Reconciliation of GAAP net income (loss) to EBITDA, a non-GAAP measure:
|
Three Months Ended |
Six Months Ended |
|||||||||||||||||
|
March 31, |
March 31, |
|||||||||||||||||
|
2019 |
2018 |
Change |
2019 |
2018 |
Change |
|||||||||||||
|
Net income (loss) |
$ |
1,265 |
$ |
1,316 |
$ |
(51) |
$ |
2,955 |
$ |
(1,535) |
$ |
4,490 |
||||||
|
(i) Interest expense |
544 |
261 |
283 |
721 |
539 |
182 |
||||||||||||
|
(ii) Provision for taxes |
517 |
627 |
(110) |
1,207 |
4,346 |
(3,139) |
||||||||||||
|
(iii) Depreciation and |
560 |
560 |
— |
1,123 |
1,066 |
57 |
||||||||||||
|
EBITDA |
$ |
2,886 |
$ |
2,764 |
$ |
122 |
$ |
6,006 |
$ |
4,416 |
$ |
1,590 |
||||||
Reconciliation of GAAP net income (loss) to net income adjusted for the effect of the 2017 Tax Act, a non-GAAP measure:
|
Six Months Ended |
|||||||||
|
March 31, |
|||||||||
|
2019 |
2018 |
Change |
|||||||
|
Net income (loss) |
$ |
2,955 |
$ |
(1,535) |
$ |
4,490 |
|||
|
Write-down of deferred tax assets |
$ |
— |
$ |
3,365 |
$ |
(3,365) |
|||
|
Pro-forma impact of tax rate change |
$ |
— |
$ |
166 |
$ |
(166) |
|||
|
Net income, adjusted for the effect of the 2017 Tax Act |
$ |
2,955 |
$ |
1,966 |
$ |
959 |
|||
|
Net income per diluted share |
$ |
0.23 |
$ |
(0.13) |
$ |
0.36 |
|||
|
Impact of write-down of deferred tax asset |
$ |
— |
$ |
0.28 |
$ |
(0.28) |
|||
|
Pro-forma impact of tax rate change |
$ |
— |
$ |
0.01 |
$ |
(0.01) |
|||
|
Net income per diluted share, adjusted for the effect of the 2017 |
$ |
0.23 |
$ |
0.16 |
$ |
0.07 |
|||
View original content:http://www.prnewswire.com/news-releases/dlh-reports-second-quarter-fiscal-year-2019-results-300845465.html
SOURCE DLH Holdings Corp.
HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…
This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…
Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…
SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…
MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the…